Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Abstract 5015: Tumor dependence on HER2 signaling as a player in immune infiltration required for trastuzumab activity

Tiziana Triulzi, Viola Regondi, Loris De Cecco, Gaia Ghedini, Maria Luisa Carcangiu, Serenella M. Pupa, Elda Tagliabue

Cancer Res (2015) 75 (15_Supplement): 5015.

https://doi.org/10.1158/1538-7445.AM2015-5015

Published: 01 August 2015

View article titled, Abstract 5015: Tumor dependence on HER2 signaling as a player in immune infiltration required for trastuzumab activity

Journal Articles

Abstract P4-15-06: Correlation between ERBB2 mRNA levels, HER2-dependence and susceptibility to trastuzumab in human breast cancer

Elda Tagliabue, Viola Regondi, Loris De Cecco, Serenella M Pupa, Manuela Campiglio, Maria Luisa Carcangiu, Sylvie Ménard, Tiziana Triulzi

Cancer Res (2015) 75 (9_Supplement): P4-15-06.

https://doi.org/10.1158/1538-7445.SABCS14-P4-15-06

Published: 01 May 2015

View article titled, Abstract P4-15-06: Correlation between ERBB2 mRNA levels, HER2-dependence and susceptibility to trastuzumab in human breast cancer

Journal Articles

Abstract LB-320: Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer.

Anna Tessari, Lorenzo Pilla, Biagio Paolini, Maria Luisa Carcangiu, Luigi Mariani, Angela Moliterni, Filippo De Braud, Sara Cresta

Cancer Res (2013) 73 (8_Supplement): LB-320.

https://doi.org/10.1158/1538-7445.AM2013-LB-320

Published: 15 April 2013

View article titled, Abstract LB-320: Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer.

Journal Articles

Abstract 1598: Vasculogenic properties of triple negative breast carcinoma cells: possible implication for new molecular target

Elda Tagliabue, Ilaria Plantamura, Erica Dugnani, Cristina Ghirelli, Monica Tortoreto, Isabella Barajon, Francesca Arnaboldi, Roberto Agresti, Maria Luisa Carcangiu, Andrea Balsari, Marilena V. Iorio

Cancer Res (2010) 70 (8_Supplement): 1598.

https://doi.org/10.1158/1538-7445.AM10-1598

Published: 15 April 2010

View article titled, Abstract 1598: Vasculogenic properties of triple negative breast carcinoma cells: possible implication for new molecular target

Journal Articles

New Potential Ligand-Receptor Signaling Loops in Ovarian Cancer Identified in Multiple Gene Expression Studies

Giancarlo Castellano, James F. Reid, Paola Alberti, Maria Luisa Carcangiu, Antonella Tomassetti, Silvana Canevari

Cancer Res (2006) 66 (22): 10709–10719.

https://doi.org/10.1158/0008-5472.CAN-06-1327

Published: 15 November 2006

View article titled, New Potential Ligand-Receptor Signaling Loops in Ovarian Cancer Identified in Multiple Gene Expression Studies

Includes: Supplementary data

Journal Articles

Transforming Growth Factor β Signaling Is Disabled Early in Human Endometrial Carcinogenesis Concomitant with Loss of Growth Inhibition

Trilok V. Parekh, Patricia Gama, Xie Wen, Rita Demopoulos, John S. Munger, Maria-Luisa Carcangiu, Michael Reiss, Leslie I. Gold

Cancer Res (2002) 62 (10): 2778–2790.

Published: 01 May 2002

View article titled, Transforming Growth Factor β Signaling Is Disabled Early in Human Endometrial Carcinogenesis Concomitant with Loss of Growth Inhibition

Journal Articles

Frequent Mutation and Nuclear Localization of β-Catenin in Anaplastic Thyroid Carcinoma

Ginesa Garcia-Rostan, Giovanni Tallini, Agustin Herrero, Thomas G. D’Aquila, Maria Luisa Carcangiu, David L. Rimm

Cancer Res (1999) 59 (8): 1811–1815.

Published: 15 April 1999

View article titled, Frequent Mutation and Nuclear Localization of β-Catenin in Anaplastic Thyroid Carcinoma

NARROW

Abstract 5015: Tumor dependence on HER2 signaling as a player in immune infiltration required for trastuzumab activity

Abstract P4-15-06: Correlation between ERBB2 mRNA levels, HER2-dependence and susceptibility to trastuzumab in human breast cancer

Abstract LB-320: Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer.

Abstract 1598: Vasculogenic properties of triple negative breast carcinoma cells: possible implication for new molecular target

New Potential Ligand-Receptor Signaling Loops in Ovarian Cancer Identified in Multiple Gene Expression Studies

Transforming Growth Factor β Signaling Is Disabled Early in Human Endometrial Carcinogenesis Concomitant with Loss of Growth Inhibition

Frequent Mutation and Nuclear Localization of β-Catenin in Anaplastic Thyroid Carcinoma

Email alerts

AACR Journals

Abstract 5015: Tumor dependence on HER2 signaling as a player in immune infiltration required for trastuzumab activity

Abstract P4-15-06: Correlation between ERBB2 mRNA levels, HER2-dependence and susceptibility to trastuzumab in human breast cancer

Abstract LB-320: Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer.

Abstract 1598: Vasculogenic properties of triple negative breast carcinoma cells: possible implication for new molecular target

New Potential Ligand-Receptor Signaling Loops in Ovarian Cancer Identified in Multiple Gene Expression Studies

Transforming Growth Factor β Signaling Is Disabled Early in Human Endometrial Carcinogenesis Concomitant with Loss of Growth Inhibition

Frequent Mutation and Nuclear Localization of β-Catenin in Anaplastic Thyroid Carcinoma

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only